Subcutaneous administration of isatuximab in patients with multiple myeloma by an on-body delivery system: results of a nurse survey

IntroductionSubcutaneous (SC) administration of the anti-CD38 antibody isatuximab (Isa) by an on-body delivery system (OBDS), plus pomalidomide-dexamethasone, has demonstrated safety and efficacy comparable to intravenous (IV) administration, with no infusion reactions and excellent local tolerabili...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Nuria Sánchez Avello, Paula Calvo Pajares, Paul Cordero, Florence Suzan, Connie Barlas
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Oncology
Assuntos:
multiple myeloma
isatuximab
administration
subcutaneous
on-body delivery system
nurse
Acceso en liña:https://www.frontiersin.org/articles/10.3389/fonc.2025.1547108/full
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares